Status: current, Defined. Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4589865013 | Infigratinib-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
4589866014 | Product containing infigratinib (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Infigratinib-containing product | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
Infigratinib-containing product | Is a | Enzyme inhibitor-containing product | false | Inferred relationship | Some | ||
Infigratinib-containing product | Is a | Protein kinase inhibitor-containing product | true | Inferred relationship | Some | ||
Infigratinib-containing product | Is a | Nitrogen and/or nitrogen compound-containing product | true | Inferred relationship | Some | ||
Infigratinib-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
Infigratinib-containing product | Has active ingredient | Infigratinib | true | Inferred relationship | Some | 1 | |
Infigratinib-containing product | Is a | Urea and/or urea derivative-containing product | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Infigratinib only product | Is a | True | Infigratinib-containing product | Inferred relationship | Some | |
Infigratinib-containing product in oral dose form | Is a | True | Infigratinib-containing product | Inferred relationship | Some |
This concept is not in any reference sets